bioRxivMicrobiology
Cas1 mediates the interference stage in a phage-encoded CRISPR-Cas system
L. Zhang, H. Wang, J. Zeng, X. Cao, Z. Gao, Z. Liu, F. Li, J. Wang, Y. Zhang, M. Yang, Y. Feng
Abstract
CRISPR-Cas systems are prokaryotic adaptive immune systems against invading phages and other mobile genetic elements, which function in three stages: adaptation, expression and interference. Interestingly, phages were also found to encode CRISPR-Cas systems to antagonize their hosts and establish infection. The Vibrio cholerae-infecting ICP1 phage was the first discovered phage with a functional CRISPR-Cas system against an antiphage region in the host genome. Nevertheless, this system lacks a domain essential for recruitment of helicase-nuclease Cas2/3 during target DNA cleavage, and how this system accomplishes the interference stage remains unknown. Here, surprisingly, we found that Cas1, a highly conserved component known to exclusively work in the adaptation stage, also mediates the interference stage through connecting Cas2/3 to the DNA bound-Cascade (Csy) complex of the ICP1 CRISPR-Cas system. A series of structures of Csy, Csy-dsDNA, Cas1-Cas2/3 and Csy-dsDNA-Cas1-Cas2/3 complexes collectively reveal the whole process of Cas1-mediated target DNA cleavage by the ICP1 CRISPR-Cas system. Together, these data support an unprecedented model in which Cas1 mediates the interference stage in a phage-encoded CRISPR-Cas system and also shed light on a unique model of primed adaptation.
- organism: bacteria (other)
- research focus: chromatin & epigenetic regulation
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Competition between mobile genetic elements drives optimization of a phage-encoded CRISPR-Cas system: Insights from a natural arms-race
A. McKitterick, K. LeGault, … K. Seed·bioRxiv·Aug 1, 2018
- A CARF-HAD phosphatase effector provides immunity during the type III-A CRISPR-Cas response
Gianna Stella, Linzhi Ye, … Luciano A. Marraffini·Nucleic Acids ResearchPeer-reviewed·Nov 26, 2025
- A chimeric nuclease substitutes CRISPR-Cas: A phage weaponizes laterally acquired specificity to destroy subviral parasites
Z. K. Barth, M. H. T. Nguyen, K. Seed·bioRxiv·Feb 21, 2021
- Phage genome cleavage enables resuscitation from Cas13-induced bacterial dormancy
M. C. Williams, A. E. Reker, … A. J. Meeske·bioRxiv·Jul 5, 2022
- Identification of spacer and protospacer sequence requirements in the Vibrio cholerae Type I-E CRISPR/Cas System
J. Bourgeois, D. W. Lazinski, A. Camilli·bioRxiv·Aug 9, 2020
- Determining the specificity of Cascade binding, interference, and primed adaptation in vivo in the Escherichia coli type I-E CRISPR-Cas system
L. Cooper, A. Stringer, J. Wade·bioRxiv·Mar 16, 2018